Scribd Logo
Upload

Welcome to Scribd!

  • 16 views

    Shantanu Fadm

    Uploaded by

    Himanshu
    This document contains financial data for the pharmaceutical companies Cipla and Dr. Reddy's from FY 2018 to FY 2022. It shows their equity, non-current liabilities, current liabilities, revenue and market capitalization over these years. Cipla's equity increased from 14,581 cr in FY 2018 to 21,117 cr in FY 2022. Dr. Reddy's revenue grew from 14,436 cr in FY 2018 to 22,099 cr in FY 2022. The document also provides a breakdown of Dr. Reddy's revenue and profitability by business segments for FY 2022, FY 2021 and FY 2020.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Shantanu Fadm

    Uploaded by

    Himanshu
    16 views12 pages
    This document contains financial data for the pharmaceutical companies Cipla and Dr. Reddy's from FY 2018 to FY 2022. It shows their equity, non-current liabilities, current liabilities, revenue and market capitalization over these years. Cipla's equity increased from 14,581 cr in FY 2018 to 21,117 cr in FY 2022. Dr. Reddy's revenue grew from 14,436 cr in FY 2018 to 22,099 cr in FY 2022. The document also provides a breakdown of Dr. Reddy's revenue and profitability by business segments for FY 2022, FY 2021 and FY 2020.

    Original Description:

    Original Title

    Shantanu fadm

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document contains financial data for the pharmaceutical companies Cipla and Dr. Reddy's from FY 2018 to FY 2022. It shows their equity, non-current liabilities, current liabilities, revenue and market capitalization over these years. Cipla's equity increased from 14,581 cr in FY 2018 to 21,117 cr in FY 2022. Dr. Reddy's revenue grew from 14,436 cr in FY 2018 to 22,099 cr in FY 2022. The document also provides a breakdown of Dr. Reddy's revenue and profitability by business segments for FY 2022, FY 2021 and FY 2020.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as xlsx, pdf, or txt
    16 views12 pages

    Shantanu Fadm

    Uploaded by

    Himanshu
    This document contains financial data for the pharmaceutical companies Cipla and Dr. Reddy's from FY 2018 to FY 2022. It shows their equity, non-current liabilities, current liabilities, revenue and market capitalization over these years. Cipla's equity increased from 14,581 cr in FY 2018 to 21,117 cr in FY 2022. Dr. Reddy's revenue grew from 14,436 cr in FY 2018 to 22,099 cr in FY 2022. The document also provides a breakdown of Dr. Reddy's revenue and profitability by business segments for FY 2022, FY 2021 and FY 2020.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as xlsx, pdf, or txt
    of 12

    Cipla

    Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022


    Equity(in cr.) 14,581.63 15,344.25 16,057.28 18,585.59 21,117.38
    Percent Increase 12.32 5.23 4.65 15.75 13.62

    Dr Reddy's Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022


    Equity(in cr.) 12,571.60 14,023.60 15,598.80 17,641.70 19,212.40
    Percent Increase 2.51 11.55 11.23 13.10 8.90
    Equity
    25,000.00

    20,000.00

    15,000.00

    10,000.00

    5,000.00

    0.00
    FY 2018 FY 2019 FY 2020 FY 2021 FY 2022

    Equity(in cr.) Equity(in cr.)


    Cipla
    Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022
    Non Current Liabilities(in cr.) 4,259.05 4,646.15 2,972.37 1,678.55 826.91
    Percentage change -5.62 9.09 -36.03 -43.53 -50.74

    Dr Reddy's Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022


    Non Current Liabilities(in cr.) 2,883.90 2,497.40 410.40 842.40 767.30
    Percentage change 195.39 -13.40 -83.57 105.26 -8.92
    Non Current liabilities
    5,000.00
    4,500.00
    4,000.00
    3,500.00
    3,000.00
    2,500.00
    2,000.00
    1,500.00
    1,000.00
    500.00
    0.00
    FY 2018 FY 2019 FY 2020 FY 2021 FY 2022

    Non Current Liabilities(in cr.) Non Current Liabilities(in cr.)


    Cipla
    Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022
    Current Liabilities(in cr.) 3,832.22 3,771.51 4,393.14 4,591.14 4,912.87

    Dr Reddy's Financial Year FY 2018 FY 2019 FY 2020 FY 2021 FY 2022


    Current Liabilities(in cr.) 6,893.80 5,897.30 7,214.10 8,103.80 9,765.80
    Current Liabilities
    12,000.00

    10,000.00

    8,000.00

    6,000.00

    4,000.00

    2,000.00

    0.00
    FY 2018 FY 2019 FY 2020 FY 2021 FY 2022

    Current Liabilities(in cr.) Current Liabilities(in cr.)


    Dr Reddy's Revenue

    FY2018 FY 2019 FY 2020


    Renenue(in Cr ) 14,436.20 15,829.50 18,193.70
    %Change 0.48% 9.64% 14.93%

    Average growth for last 5 years 8.99% Renen


    Industry average growth rate 7.71% 25,000.00

    20,000.00

    15,000.00

    10,000.00

    5,000.00

    0.00
    FY2018 FY 2019
    FY 2021 FY 2022
    19,386.90 22,099.90
     12%  8.94%

    Renenue(in Cr )

    FY2018 FY 2019 FY 2020 FY 2021 FY 2022


    Dr Reddy's
    Dr Reddy's Market C
    Year Market cap(Bn INR) Change 1000
    900
    2018 491.88 -0.74% 800
    700
    2019 532.8 7.40% 600
    2020 940 76.37% 500
    400
    2021 875.2 -6.90% 300
    200
    2022 698.4 -20.14% 100
    0
    2018 2019 2020
    Cipla
    Year Market cap(Bn INR) Change
    2018 479.2 -21.46%
    Cipla Market Cap
    2019 432 -9.72% 900
    800
    2020 723.2 67.13% 700
    2021 818.4 13.22% 600
    500
    2022 832 1.66% 400
    300
    200
    100
    0
    2018 2019 2020
    Dr Reddy's Market Cap(Bn INR)
    00
    00
    00
    00
    00
    00
    00
    00
    00
    00
    0
    2018 2019 2020 2021 2022

    Cipla Market Cap(Bn INR)


    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    2018 2019 2020 2021 2022
    Dr Reddy's
    Revenue by segments(in cr.)
    Particulars FY 2022 FY 2021 FY 2020
    Global generics 116550 106156 89683
    Pharmaceutical services and active ingredients 25013 26188 20703
    Proprietary products 1590 470 7644
    143154 132814 118030

    Profitability Ratios(in %)
    Particulars FY 2022 FY 2021 FY 2020
    Global generics 59 57 59
    Pharmaceutical services and active ingredients 29 25 24
    Revenue
    140000
    120000
    100000
    80000
    60000
    40000
    20000
    0
    FY 2022 FY 2021 FY 2020

    Global generics
    Pharmaceutical services and active ingredients
    Proprietary products

    Profitability Ratio
    70
    60
    50
    40
    30
    20
    10
    0
    FY 2022 FY 2021 FY 2020

    Global generics
    Pharmaceutical services and active ingredients

    You might also like